Feb 28, 2017 21:06 pm UTC| Business
ENGLEWOOD, Colo., Feb. 28, 2017 -- Ascent Capital Group, Inc. (“Ascent” or the “Company”) (Nasdaq:ASCMA) has reported results for the three and twelve months ended December 31, 2016. Ascent is a holding company that...
Feb 28, 2017 21:06 pm UTC| Business
ENGLEWOOD, Colo., Feb. 28, 2017 -- Ascent Capital Group, Inc. (“Ascent” or the “Company”) (Nasdaq:ASCMA) has reported results for the three and twelve months ended December 31, 2016. Ascent is a holding company that...
Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2016
Feb 28, 2017 21:06 pm UTC| Business
EMERYVILLE, Calif., Feb. 28, 2017 -- Adamas Pharmaceuticals,Inc. (Nasdaq:ADMS) today reported recent achievements and financial results for the fourth quarter and full-year ended December 31, 2016. “We expect 2017 to...
Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2016
Feb 28, 2017 21:06 pm UTC| Business
EMERYVILLE, Calif., Feb. 28, 2017 -- Adamas Pharmaceuticals,Inc. (Nasdaq:ADMS) today reported recent achievements and financial results for the fourth quarter and full-year ended December 31, 2016. “We expect 2017 to...
PRA Group Announces CEO Succession Plan
Feb 28, 2017 21:06 pm UTC| Business
Kevin Stevenson to become CEO following Annual Meeting in June 2017;Steve Fredrickson will become executive chairman of the PRA Board of Directors NORFOLK, Va., Feb. 28, 2017 -- PRA Group, Inc. (Nasdaq:PRAA), a global...
PRA Group Announces CEO Succession Plan
Feb 28, 2017 21:06 pm UTC| Business
Kevin Stevenson to become CEO following Annual Meeting in June 2017;Steve Fredrickson will become executive chairman of the PRA Board of Directors NORFOLK, Va., Feb. 28, 2017 -- PRA Group, Inc. (Nasdaq:PRAA), a global...
Otonomy to Present at Cowen and Company Health Care Conference
Feb 28, 2017 21:06 pm UTC| Business
SAN DIEGO, Feb. 28, 2017 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that...